|
MDiT Forum and Regulation Summit 2022—— Technology Track G: The 8th IIMD China Summit-Implantable and Interventional Medical Device
December 7 | Conference Room E, Hall E1, SUZHOU INTERNATIONAL EXPO CENTER
Co-organizers: Medtec China
|
|
Conference Background:
- Recently, Allied Market Research published the report "Global Medical Implants Market Analysis and Industry Forecast for 2020-2027", covering different product types (orthopedic implants, cardiovascular implants, spinal implants, nerve stimulators, ophthalmic implants, dental implants, facial implants, and breast implants) as well as biomedical material types (bio metallic materials, bioceramic materials, biopolymer materials, and natural biomaterials). According to the report, the medical implants market is estimated at USD 85.38 billion in 2019 and is expected to reach USD 147.46 billion by 2027, growing at a CAGR of 7.2% from 2020 to 2027.
- In the context of China's aging trend and the high prevalence of cardiovascular and orthopaedic diseases, the market demand for cardiovascular and orthopaedic implant devices is increasingly huge, showing a trend of import substitution and multidisciplinary integration. Based on the division of product types, the orthopaedic implant market holds the largest market share, and according to Evaluate MedTec's forecast, the global orthopaedic implant medical device industry is projected to reach a market size of 47.1 billion US dollars by 2024.
- Medtec China organized IIMD China Summit from the year of 2012 for 8 sessions. This conference focus on content of regulation requirement, market trend, key technologies, and material development in IIMD area.
Who Should Attend?
- R&D, Design and Compliance and Technology Department, Project Manager/Director and Managing Director from IIMD manufacturers
- Biomedical materials manufacturers
- Suppliers of raw material, design, process technology and solution
- Clinicians, testing organization and research institution
*Conference agenda updates according to speaker confirming.
|
|
Geng Cui, Chief Physician, Associate Professor, Orthopedics Department of Chinese PLA General Hospital （Pending）
Yufeng Zheng，Professor, Department of Materials Science and Engineering, College of Engineering, Peking University
Xufeng Wei, Director & Deputy Director of Cardiac surgery, Scientific Research Department, Ming Xin Cardiovascular Disease Hospital of Wuxi
Yongqiang Hao, Chief Physician; Professor, Orthopaedic Department of Shanghai Ninth People’s Hospital，Shanghai JiaoTong University School of Medicine
Leo Jiang, GM, Anhui Jingwei Micdical Material Technology Co.,Ltd
Shuming Zhang, Sales & Marketing Director, Saint-Gobain Performance Plastics (Shanghai) Co.,LTD.
Cai Wenjing,project director（官网多Geng Cui） ,Shanghai Applied Protein Technology Co., Ltd.
|
|
Saint-Gobain Performance Plastics (Shanghai) Co.,LTD.
Shanghai Applied Protein Technology Co., Ltd.
Anhui Jingwei Micdical Material Technology Co.,Ltd
Saint-Gobain Performance Plastics (Shanghai) Co.,LTD.
|